Samstag, 21. Oktober 2017

  • Pressemitteilung BoxID 48574

PULSION and Philips Healthcare extend their strategic collaboration

München, (lifePR) - PULSION Medical Systems AG, specialist in minimally invasive cardiovascular monitoring of critically ill patients, and Philips Healthcare, worldwide market leader in patient monitoring, have agreed to extend their successful strategic partnership. The agreement covers several areas of collaboration including future integration of PULSION technologies into Philips patient monitoring systems. In the past, Philips Healthcare was the first leading manufacturer of patient monitoring systems to integrate PULSION's flagship technology PiCCO. Since then, more than 11,000 modules have been installed worldwide.

Signing this agreement marks a further step in PULSION's strategy of speeding up the global market penetration of its product lines by integration into multi-parameter monitoring systems of the major med-tech manufacturers.
Diese Pressemitteilung posten:

PULSION Medical Systems SE

PULSION Medical Systems AG, founded in 1990, has become one of the leading specialists for intelligent medical diagnosis and therapy management systems and has been listed on the Stock Exchange in Frankfurt since 2001. The repeated development of innovative product lines in the medtech field is the basis for creation and expansion of the attractive disposable business with sterile products and pharmaceuticals. The business unit PULSION Critical Care covering intensive care medicine, perioperative medicine and emergency medicine focuses on the management of cardiovascular and organ functions of critically ill patients. Products and activities of the business unit PULSION Pharma are directed at the diagnosis and therapy management of organ and tissue perfusion in ophthalmology, surgery and hepatology. PULSION products are marketed worldwide via own sales channels or secondary distribution. All products are certified with the CE mark which is basis for marketing in the EU and some other countries. The US-American FDA approval and the Japanese market approval have been issued for selected product lines. Further information about PULSION is available at

Weitere Pressemitteilungen dieses Herausgebers